Allopurinol Designated an Orphan Drug for Marfa...

By João L. Carapinha

May 30, 2025

The European Medicines Agency (EMA) recently granted orphan drug designation to allopurinol for treating Marfan syndrome - a rare genetic disorder. It affects connective tissue and can lead to life-threatening aortic aneurysms. This designation, t...

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.